SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J.-C. Trinchet, Carcinome hépatocellulaire en 2014 : situation actuelle et perspectives, Journal de Radiologie Diagnostique et Interventionnelle, 2014, 95, 7-8, 693

    CrossRef

  2. 2
    Moana Gelu-Simeon, Rodolphe Sobesky, Stéphanie Haïm-Boukobza, Marita Ostos, Elina Teicher, Hélène Fontaine, Dominique Salmon-Ceron, Laurence Meyer, Jean-Claude Trinchet, Bernard Paule, Didier Samuel, Maïté Lewin, Jean-Charles Duclos-Vallée, Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIV-infected patients justify specific screening policies?, AIDS, 2014, 28, 10, 1379

    CrossRef

  3. 3
    Sarwat Fatima, John M Luk, Ronnie TP Poon, Nikki P Lee, Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma, Expert Review of Molecular Diagnostics, 2014, 14, 5, 535

    CrossRef

  4. 4
    Rodolfo Sacco, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Giuseppe Cabibbo, EASL HCC summit: liver cancer management, Future Oncology, 2014, 10, 7, 1129

    CrossRef

  5. 5
    Jean-Baptiste Trabut, Véronique Thépot, Benoit Terris, Philippe Sogni, Bertrand Nalpas, Stanislas Pol, Évaluation pronostique de la maladie alcoolique du foie : comment et pourquoi ?, La Presse Médicale, 2014, 43, 2, 124

    CrossRef

  6. 6
    Paolo Del Poggio, Stefano Olmi, Francesca Ciccarese, Mariella Di Marco, Gian Ludovico Rapaccini, Luisa Benvegnù, Franco Borzio, Fabio Farinati, Marco Zoli, Edoardo Giovanni Giannini, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis, Clinical Gastroenterology and Hepatology, 2014,

    CrossRef

  7. 7
    Cemal Yazici, David J Niemeyer, David A Iannitti, Mark W Russo, Hepatocellular carcinoma and cholangiocarcinoma: an update, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 63

    CrossRef

  8. 8
    J.-C. Trinchet, Hepatocellular carcinoma in 2014: Current situation and future prospects, Diagnostic and Interventional Imaging, 2014, 95, 7-8, 705

    CrossRef

  9. 9
    Abbas Mourad, Sylvie Deuffic-Burban, Nathalie Ganne-Carrié, Thibaud Renaut-Vantroys, Isabelle Rosa, Anne-Marie Bouvier, Guy Launoy, Stephane Cattan, Alexandre Louvet, Sébastien Dharancy, Jean-Claude Trinchet, Yazdan Yazdanpanah, Philippe Mathurin, Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach, Hepatology, 2014, 59, 4
  10. 10
    Do Young Kim, Kwang-Hyub Han, Impact of a shortened surveillance interval on hepatocellular carcinoma survival, Hepatic Oncology, 2014, 1, 1, 3

    CrossRef

  11. 11
    Arige Tarhuni, Erwan Guyot, Pierre Rufat, Angela Sutton, Valérie Bourcier, Véronique Grando, Nathalie Ganne-Carrié, Marianne Ziol, Nathalie Charnaux, Michel Beaugrand, Richard Moreau, Jean-Claude Trinchet, Abdellah Mansouri, Pierre Nahon, Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis, Journal of Hepatology, 2014, 61, 2, 342

    CrossRef

  12. 12
    J.F. Schlaak, Labordiagnostik bei primärem Leberzellkarzinom, Der Gastroenterologe, 2014, 9, 2, 138

    CrossRef

  13. 13
    Morris Sherman, Limitations of screening for hepatocellular carcinoma, Hepatic Oncology, 2014, 1, 2, 161

    CrossRef

  14. 14
    Xingshun Qi, Guohong Han, Daiming Fan, Management of portal vein thrombosis in liver cirrhosis, Nature Reviews Gastroenterology & Hepatology, 2014, 11, 7, 435

    CrossRef

  15. 15
    Xiaofei Li, Wenjun Yang, Lianqing Lou, Yongxin Chen, Shuang Wu, Guoqiang Ding, microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma, Digestive Diseases and Sciences, 2014, 59, 6, 1099

    CrossRef

  16. 16
    Jae-Jun Shim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Byung-Ho Kim, Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2014, 29, 9
  17. 17
    Etsushi Kawamura, Susumu Shiomi, Kohei Kotani, Joji Kawabe, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Shuji Iwai, Hiroyasu Morikawa, Masaru Enomoto, Yoshiki Murakami, Akihiro Tamori, Norifumi Kawada, Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2014, 29, 9
  18. 18
    Dipanjan Panda, Role of Surveillance in Prevention of Hepatocellular Carcinoma, Journal of Clinical and Experimental Hepatology, 2014, 4, S43

    CrossRef

  19. 19
    Jeyamani Ramachandran, Surveillance for Hepatocellular Carcinoma, Journal of Clinical and Experimental Hepatology, 2014, 4, S50

    CrossRef

  20. 20
    Mohamed G. Shoreibah, Joseph R. Bloomer, Brendan M. McGuire, Omar I. Massoud, Surveillance for Hepatocellular Carcinoma, The American Journal of the Medical Sciences, 2014, 347, 5, 415

    CrossRef

  21. 21
    Zhi Ven Fong, Kenneth K. Tanabe, The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review, Cancer, 2014, 120, 18
  22. 22
    Ashish Kumar, Subrat K. Acharya, Shivaram P. Singh, Vivek A. Saraswat, Anil Arora, Ajay Duseja, Mahesh K. Goenka, Deepali Jain, Premashish Kar, Manoj Kumar, Vinay Kumaran, Kunisshery M. Mohandas, Dipanjan Panda, Shashi B. Paul, Jeyamani Ramachandran, Hariharan Ramesh, Padaki N. Rao, Samir R. Shah, Hanish Sharma, Ragesh B. Thandassery, The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations, Journal of Clinical and Experimental Hepatology, 2014, 4, S3

    CrossRef

  23. 23
    Luca Di Tommaso, Angelo Sangiovanni, Mauro Borzio, Young Nyun Park, Fabio Farinati, Massimo Roncalli, Advanced precancerous lesions in the liver, Best Practice & Research Clinical Gastroenterology, 2013, 27, 2, 269

    CrossRef

  24. 24
    Kai Zhu, Zhi Dai, Jian Zhou, Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy, Biomarker Research, 2013, 1, 1, 10

    CrossRef

  25. 25
    Alessandro Cucchetti, Matteo Cescon, Virginia Erroi, Antonio D. Pinna, Cost-effectiveness of liver cancer screening, Best Practice & Research Clinical Gastroenterology, 2013, 27, 6, 961

    CrossRef

  26. 26
    Marianne Ziol, Angela Sutton, Julien Calderaro, Nathalie Barget, Mounir Aout, Vincent Leroy, Jean-Frédéric Blanc, Nathalie Sturm, Paulette Bioulac-Sage, Pierre Nahon, Jean-Charles Nault, Nathalie Charnaux, Gisèle N’Kontchou, Jean-Claude Trinchet, Maryse Delehedde, Olivier Seror, Michel Beaugrand, Eric Vicaut, Nathalie Ganne-Carrié, ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma, Journal of Hepatology, 2013, 59, 6, 1264

    CrossRef

  27. 27
    V. Cartier, C. Aubé, Gastrointestinal imaging: Tips and traps in the diagnosis of small HCC, Diagnostic and Interventional Imaging, 2013, 94, 7-8, 697

    CrossRef

  28. 28
    Jing-Houng Wang, Kuo-Chin Chang, Kwong-Ming Kee, Pao-Fei Chen, Yi-Hao Yen, Po-Lin Tseng, Yuan-Hung Kuo, Ming-Chao Tsai, Chao-Hung Hung, Chien-Hung Chen, Wei-Chen Tai, Lin-San Tsai, Shu-Chuan Chen, Sheng-Che Lin, Sheng-Nan Lu, Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community, The American Journal of Gastroenterology, 2013, 108, 3, 416

    CrossRef

  29. 29
    V. Cartier, C. Aubé, Imagerie digestive : pièges et astuces – diagnostic du petit CHC, Journal de Radiologie Diagnostique et Interventionnelle, 2013, 94, 7-8, 708

    CrossRef

  30. 30
    Dong Hyun Sinn, Jieun Yi, Moon Seok Choi, Dongil Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance, Hepatology International, 2013, 7, 4, 1010

    CrossRef

  31. 31
    Massimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, Peter R. Galle, Jessica Zucman-Rossi, Rafael Bañares, Daniel Seehofer, Peter Neuhaus, Philip Johnson, Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma, European Journal of Gastroenterology & Hepatology, 2013, 25, 6, 639

    CrossRef

  32. 32
    Erwan Guyot, Angela Sutton, Pierre Rufat, Christelle Laguillier, Abdellah Mansouri, Richard Moreau, Nathalie Ganne-Carrié, Michel Beaugrand, Nathalie Charnaux, Jean-Claude Trinchet, Pierre Nahon, PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis, Journal of Hepatology, 2013, 58, 2, 312

    CrossRef

  33. 33
    Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma, Digestive and Liver Disease, 2013, 45, 9, 712

    CrossRef

  34. 34
    Jean-Charles Nault, Predisposition to hepatocellular carcinoma: Clues in sex chromosomes, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 6, 547

    CrossRef

  35. 35
    C. Pocha, E. Dieperink, K. A. McMaken, A. Knott, P. Thuras, S. B. Ho, Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography – a randomised study, Alimentary Pharmacology & Therapeutics, 2013, 38, 3
  36. 36
    Molly Hassett, Adam C. Yopp, Amit G. Singal, Surveillance for Hepatocellular Carcinoma, The American Journal of the Medical Sciences, 2013, 346, 4, 308

    CrossRef

  37. 37
    Kwang-Hyub Han, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Jieun Kim, Seung Up Kim, Ja Kyung Kim, Kwan Sik Lee, Chae Yoon Chon, Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months, Journal of Clinical Gastroenterology, 2013, 47, 6, 538

    CrossRef

  38. 38
    Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim, The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011, Korean Journal of Medicine, 2013, 84, 5, 672

    CrossRef

  39. 39
    S Zaltron, A Spinetti, L Biasi, C Baiguera, F Castelli, Chronic HCV infection: epidemiological and clinical relevance, BMC Infectious Diseases, 2012, 12, Suppl 2, S2

    CrossRef

  40. 40
    EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma, European Journal of Cancer, 2012, 48, 5, 599

    CrossRef

  41. 41
    Alejandro Forner, Josep M Llovet, Jordi Bruix, Hepatocellular carcinoma, The Lancet, 2012, 379, 9822, 1245

    CrossRef

  42. 42
    Valentyn Usachov, Pierre Nahon, Mariia Lunova, Marianne Ziol, Pierre Rufat, Angela Sutton, Michel Beaugrand, Pavel Strnad, Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma, BMC Gastroenterology, 2012, 12, 1, 147

    CrossRef

  43. 43
    Carlos Rodríguez de Lope, Silvia Tremosini, Alejandro Forner, María Reig, Jordi Bruix, Management of HCC, Journal of Hepatology, 2012, 56, S75

    CrossRef

  44. 44
    C. Marquardt, A. Stallmach, Neue Erkenntnisse und Strategien einer rationalen Diagnostik und Bildgebung bei primären Lebertumoren, Der Onkologe, 2012, 18, 7, 583

    CrossRef

  45. 45
    Cristina Della Corte, Massimo Colombo, Surveillance for Hepatocellular Carcinoma, Seminars in Oncology, 2012, 39, 4, 384

    CrossRef

  46. 46
    Jordi Bruix, Maria Reig, Jordi Rimola, Alejandro Forner, Marta Burrel, Ramón Vilana, Carmen Ayuso, Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques, Hepatology, 2011, 54, 6
  47. 47
    Angelo Sangiovanni, Massimo Colombo, Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option, Hepatology, 2011, 54, 6
  48. 48
    Alejandro Forner, Carmen Ayuso, Jordi Bruix, Hepatocellular Carcinoma,